Skip to content

Clinical trials

Withdrawn Autism Spectrum Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Status: Withdrawn Country / region: United States Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111
20142
20151
20161
20181
20192
20203
20214
20222
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)2
Beth Israel Deaconess Medical Center1
Boston University Charles River Campus1
Cognoa, Inc.1
Duke University1
Father Flanagan's Boys' Home1
Floreo, Inc.1
Jazz Pharmaceuticals1
Massachusetts General Hospital1
Milton S. Hershey Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder22
Autistic Disorder10
Child Development Disorders, Pervasive4
Anxiety Disorders2
Akinetic Mutism1
Antisocial Personality Disorder1
Asperger Syndrome1
Developmental Disabilities1
Fragile X Syndrome1
Intellectual Disability1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.